Ihuman Inc Stock Today
| IH Stock | USD 1.64 0.08 5.13% |
Performance3 of 100
| Odds Of DistressLess than 18
|
Ihuman is trading at 1.64 as of the 28th of November 2024. This is a 5.13 percent increase since the beginning of the trading day. The stock's open price was 1.56. Ihuman has less than a 18 % chance of experiencing some financial distress in the next two years of operation, but did not have a good performance during the last 90 trading days. Equity ratings for Ihuman Inc are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 9th of December 2022 and ending today, the 28th of November 2024. Click here to learn more.
Business Domain Consumer Services | IPO Date 9th of October 2020 | Category Consumer Defensive | Classification Consumer Discretionary |
iHuman Inc. provides intellectual development products to individual users, kindergartens, and distributors in the Peoples Republic of China. The company was founded in 1996 and is based in Beijing, the Peoples Republic of China. Ihuman Inc operates under Education Training Services classification in the United States and is traded on New York Stock Exchange. The company has 23.57 M outstanding shares of which 6.13 K shares are currently sold short in the market by investors with about 0.29 days to cover all shorted shares. More on Ihuman Inc
Moving together with Ihuman Stock
Moving against Ihuman Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Ihuman Stock Highlights
| CEO | Peng Dai | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Ideas | Showing 3 out of 4 themes | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Hotels, Restaurants & Leisure, Education & Training Services, Consumer Discretionary, NYSE Composite, Books, Railroads, Personal Services, Education, Consumer Discretionary, Hotels, Restaurants & Leisure, Education & Training Services, Consumer Defensive (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsIhuman can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Ihuman's financial leverage. It provides some insight into what part of Ihuman's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ihuman Inc (IH) is traded on New York Stock Exchange in USA. It is located in Building B, Beijing, China, 100102 and employs 783 people. Ihuman is listed under Hotels, Restaurants & Leisure category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a market capitalization of 81.7 M. Ihuman Inc is active under Hotels, Restaurants & Leisure sector as part of Consumer Discretionary industry. The entity has 23.57 M outstanding shares of which 6.13 K shares are currently sold short in the market by investors with about 0.29 days to cover all shorted shares.
Ihuman Inc reports about 1.05 B in cash with 172.12 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 16.08, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Ihuman Probability Of Bankruptcy
Ownership AllocationIhuman Inc has a total of 23.57 Million outstanding shares. Roughly 99.39 (percent) of Ihuman outstanding shares are held by general public with 0.61 pct. by outside corporations. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Ihuman Ownership Details
Ihuman Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Arisaig Partners (asia) Pte Ltd | 2024-06-30 | 1.2 M | |
| Citadel Advisors Llc | 2024-09-30 | 38.4 K | |
| Morgan Stanley - Brokerage Accounts | 2024-06-30 | 35.4 K | |
| State Street Corp | 2024-06-30 | 26 K | |
| Rhumbline Advisers | 2024-06-30 | 11.4 K | |
| Crédit Agricole S.a. | 2024-06-30 | 10 K | |
| Qube Research & Technologies | 2024-06-30 | 14.0 | |
| Susquehanna International Group, Llp | 2024-06-30 | 0.0 | |
| Xtx Topco Ltd | 2024-09-30 | 0.0 |
Ihuman Historical Income Statement
Ihuman Stock Against Markets
Ihuman Corporate Management
| Wendy Hayes | Independent Director | Profile | |
| Yufeng Chi | Chairman of the Board | Profile | |
| Xuenan Li | Independent Director | Profile | |
| Hanfeng Chi | Director | Profile |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Ihuman Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Is Hotels, Restaurants & Leisure space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ihuman. If investors know Ihuman will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ihuman listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.40) | Earnings Share (0.16) | Revenue Per Share 18.263 | Quarterly Revenue Growth (0.11) | Return On Assets 0.0456 |
The market value of Ihuman Inc is measured differently than its book value, which is the value of Ihuman that is recorded on the company's balance sheet. Investors also form their own opinion of Ihuman's value that differs from its market value or its book value, called intrinsic value, which is Ihuman's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ihuman's market value can be influenced by many factors that don't directly affect Ihuman's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ihuman's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ihuman is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ihuman's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.